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C-ﬁbersTau protein hyperphosphorylation and consequent malfunction are hallmarks of Alzheimer's disease pathology;
importantly, pain perception is diminished in these patients. In physiological conditions, Tau contributes to cyto-
skeletal dynamics and in this way, inﬂuences a number of cellular mechanisms including axonal trafﬁcking,
myelination and synaptic plasticity, processes that are also implicated in pain perception. However, there is no
in vivo evidence clarifying the role of Tau in nociception. Thus, we tested Tau-null (Tau−/−) and Tau+/+
mice for acute thermal pain (Hargreaves' test), acute and tonic inﬂammatory pain (formalin test) andmechanical
allodynia (Von Frey test). We report that Tau−/− animals presented a decreased response to acute noxious
stimuli when compared to Tau+/+while their pain-related behavior is augmented under tonic painful stimuli.
This increased reactivity to tonic pain was accompanied by enhanced formalin-evoked c-fos staining of second
order nociceptive neurons at Tau-null dorsal horn. In addition, we analyzed the primary afferents conveying no-
ciceptive signals, estimating sciatic nerve ﬁber density, myelination and nerve conduction. Ultrastructural anal-
ysis revealed a decreased C-ﬁber density in the sciatic nerve of Tau-null mice and a hypomyelination of
myelinated ﬁbers (Aδ-ﬁbers) – also conﬁrmed by western blot analysis – followed by altered conduction prop-
erties of Tau-null sciatic nerves. To our knowledge, this is the ﬁrst in vivo study that demonstrates that Tau de-
pletion negatively affects the main systems conveying nociceptive information to the CNS, adding to our
knowledge about Tau function(s) that might also be relevant for understanding peripheral neurological deﬁcits
in different Tauopathies.
© 2014 Elsevier Inc. All rights reserved.Introduction
Taumalfunction, through its abnormal hyperphosphorylation, is pos-
tulated as a crucialmechanismof Alzheimer's disease (AD) neuronal dys-
function but it remains unknown whether Tau protein could be a direct
or indirect contributor to altered pain processing found in AD patients
(Corbett et al., 2012). The predominant view about Tau function focuses
on its key cytoskeletal role based on its ability to bind to microtubules
(MT) and other cytoskeletal elements (Mandelkow and Mandelkow,
2012). Interestingly, neuropathic pain is a common side effect of MT-
targeting agents commonly used in the clinics as chemotherapeuticethyl-D-aspartate; CNS, central
icrotubules; MBP, myelin basic
ces School, University of Minho,
usa),drugs (e.g. vincristine, paclitaxel) (Jaggi and Singh, 2012). In addition, a
growing body of evidence suggests that Tau has an important role in
the dendritic compartment where, via interaction with Fyn, contributes
to NMDA receptor/PSD95 complex formation (Frandemiche et al.,
2014; Ittner and Gotz, 2011) that has an established role in pain-
related sensitization (D'Mello et al., 2011). There is also direct evidence
of Fyn involvement on pain sensitization through phosphorylation of
the NMDA NR2B subunit (Abe et al., 2005). Furthermore, Fyn constitu-
tional activation results in hyperalgesia in naive mice (Liu et al., 2014).
Moreover, a cell culture-based study suggests that Tau–Fyn interaction
may be involved in myelination regulation (Klein et al., 2002), which is
of relevance for optimal axonal function and, consequently, for nocicep-
tive transmission. Furthermore, there is also evidence that other
cytoskeletal elements may be involved in pain as disruptors of microtu-
bules, actinﬁlaments and neuroﬁlaments in primary afferent nociceptors
interfere with normal pain sensation (Reichling and Levine, 2011) rein-
forcing the importance of understanding the relation between cytoskel-
etal proteins and pain.
487I. Sotiropoulos et al. / Experimental Neurology 261 (2014) 486–493An initial step for pain perception is the activation of peripheral
nociceptors which generates a local depolarization conveyed by speciﬁc
ﬁbers to secondary afferent neurons in the dorsal horn. Responding to
mechanical, thermal and/or chemical stimuli, Aδ ﬁbers are the small-
diameter myelinated ﬁbers that participate in the transmission of nox-
ious stimuli together with the unmyelinated C-ﬁbers. Myelination
problems as well as reduced number of ﬁbers in sciatic nerve have
been shown to affect pain perception and pain circuitry function
(Chen et al., 2003). While previous ﬁndings described alterations in
small-caliber axons of animals lacking Tau protein (Harada et al.,
1994), and despite the suggestion that Tau protein is implicated in
myelination processes (Klein et al., 2002), yet, surprisingly, to the best
of our knowledge, there is no in vivo evidence clarifying the role of
Tau in nociception. Thus, herein, we assessed pain behavior in animals
lacking Tau followed by ultrastructure, molecular and electrophysiolog-
ical analysis of their sciatic nerve.
Materials and methods
Animals
This study used 4–6 month-old male Tau-null (Tau−/−) and
Tau+/+ (C57BL/6) animals (Dawson et al., 2001). Adult Tau-null ani-
mals of this strain exhibited no cognitive or locomotor deﬁcits as previ-
ously described (Dawson et al., 2010; Gotz et al., 2013). All animalswere
used in accordance with European Union Council Directive 86/609/EEC
and local welfare regulations. Mice were housed in groups of 4 to 5 an-
imals per cage under standard environmental conditions (ambient tem-
perature of 21±1 °C and a relative humidity of 50–60%; 12 h light/dark
cycle (lights on at 8:00 A.M.) ad libitum access to food and water).
Pain-related behaviors
Hargreaves' test (acute thermal noxious stimulus)
Animals (N = 18–20 per genotype) were submitted to Hargreaves'
test which consists of a radiant heat applied to the plantar skin of the
hind limb and withdrawal latency was automatically registered using
radiant heat equipment (Plantar Test Device Model 7370, Ugo Basile,
Comerio, Italy) as previously described (Pinto-Ribeiro et al., 2013).
After acclimatization period, the measurement was repeated 4 times
with 60 second intervals. Cut-off time was 10 s. The experimenter was
blind to the animals' genotype.
Formalin test (inﬂammatory stimulus)
The formalin test was performed as previously described (Almeida
et al., 1999). Brieﬂy, 50 μL of 5% formalin was injected subcutaneously
in the dorsal surface of the right hind-paw. Animals were then placed
over a transparent acrylic surface within a 10 cm3 transparent acrylic
boxwith perforations in all walls for proper air ventilation and sufﬁcient
space for animals to freely move. Animals were ﬁlmed from below for
60 min and pain-related behaviors (paw protection/licking periods
and paw jerks) in the acute (0–5 min) and tonic (15–60 min) phases
were posteriorly quantiﬁed by two independent observers using
EthoLog software (Ottoni, 2000). Prior to the experiment, animals
were acclimatized to the experimental conditions tominimize potential
stress effects. Experimental groups for Tau-null and Tau+/+ were di-
vided in: saline-injected (control) animals (Sal; N = 10) and
formalin-injected animals (Form; N = 13–15). The experimenter was
blind to the animals' genotype and drug.
Von Frey test (up-and-down method)
Tactile allodynia (pain evoked by a normally innocuous stimulus)
was accessed by the up-and-down method (Chaplan et al., 1994). Ani-
mals (10–11 animals per group) were placed in an elevated grid and
the glabrous skin of the hind paw was probed with a series of Von
Frey calibrated monoﬁlaments: 2.0 g, 1.0 g, 0.6 g, 0.4 g, 0.16 g, 0.07 g,and 0.04 g (North Coast Medical Inc., USA). Starting with the 0.4 g ﬁla-
ment, the test would advance upward if no response was elicited
(=0) or downward if a brisk withdrawn of the limb was produced
(=X) until 6 measurements were obtained around the threshold
point according to the model developed by Dixon (1980). The 50%
response thresholdwas then calculated using the formula 50% g thresh-
old = (10^[Xf + K.δ]) / 10.000, where Xf = value (in log units) of the
ﬁnal Von Frey ﬁlament; k = tabular value corresponding to pattern of
positive and negative responses (X and O sequences; consult (Chaplan
et al., 1994)); δ = mean difference (in log units) between stimuli
(0.267). If no response (=O) was obtained up to maximal force
(2.0 g) or conversely, if all ﬁlaments elicited a response (=X) down to
theminimal force (0.04 g), these values were assumed as the 50% with-
drawal threshold. The experimenter was blind to the animals' genotype
while animals were habituated to the experimental conditions for
2 days before the experiment to minimize potential stress effects.
c-fos immunohistochemistry and density estimation
90min after formalin test completion, animalswere deeply anesthe-
tized with sodium pentobarbital (CEVA Saúde Animal, Portugal) and
then perfused through the ascending aorta with PBS followed with 4%
paraformaldehyde in PBS. The spinal cord was removed and immersed
in the same ﬁxative for 24 h at room temperature (RT) and then,
moved to an 8% sucrose solution and kept at 4 °C until use. 50 μm coro-
nal sections of the lumbar areawere then obtained in a vibratome (Leica
1000VTS) and serially collected in PBS. For c-fos IHC, sectionswere incu-
bated in 3.3% H2O2 (in PBS, pH 7.2) for 30min, RT and then, after several
washes in PBS and 0.3% PBS-T (Triton-X-100; Sigma), incubated in 2.5%
FBS (fetal bovine serum; StemCell, 062-00) in PBS-T 2 hour RT, followed
by a solution of 1:2000 anti-Fos (Calbiochem, PC38-100) and 2.0% FBS in
PBS-T overnight at RT. Sections were then washed several times in PBS-
T and incubated for 1 h, RT in a solution of 1:200 biotinylated swine
anti-rabbit secondary antibody (Dako, E0353). Sections were then
washed in PBS-T and incubated for 1 h, RT in a solution of 1:200 avi-
din–biotin complex (ABC, Vector Laboratories). Sections were again
washedwith PBS-T, PBS and Tris–HCL (0.05M, pH 7.6) and brieﬂy incu-
bated in 0.0005% (w/v) diaminobenzidine tetrahydrochloride (DAB;
Sigma Immunochemicals, St. Louis, USA), 0.0002% H2O2 (v/v) in Tris–
HCl. Sections were then serially placed in Superfrost Plus slides
(Menzel-Gläser, Braunschweig, Germany), dehydrated and mounted
in Entellan (Merck, Darmstadt, Germany). An Olympus BX51 micro-
scope equipped with U-MAD3 camera was used to acquire images
from the left and right dorsal horn of spinal cord. c-fos densitywasman-
ually determined in speciﬁc outer (laminae I–II) and deeper (laminae
III–V) regions by an experimenter (AL) blind to the samples prove-
nience (i.e. saline or formalin of both genotypes; 5–6 animals per
group).
Sciatic nerve ultrastructure analysis
Sciatic nerves of undisturbed Tau-null and Tau+/+ animals were
collected and ﬁxed in 4% glutaraldehyde in 0.1 M sodium cacodylate
buffer pH 7.4 for 1 week. Then, they were postﬁxed in 1% OsO4,
dehydrated and embedded in epon (Electron Microscopy Sciences).
1 μm thick transverse sections covering the complete cross-sectional
nerve area were stained with 1% p-phenylene diamine (PPD) for
10 min and mounted on Entellan (Merck). An Olympus DP70 was
used to photograph the transverse sections of the nerve and images
were mounted on Photoshop. For each animal (N= 5–6 per genotype),
the total number of myelinated ﬁbers in one transverse section was
counted. The g-ratio [axon diameter / (axon diameter + myelin thick-
ness)] was determined through the analysis of at least 100 ﬁbers. For
electron microscopy, ultrathin-sections (60 nm) were counterstained
with alcoholic uranyl acetate solution, followed by aqueous uranyl ace-
tate solution and lead citrate. Grids were observed on a JEOL JEM-1400
transmission electron microscope equipped with an Orius Sc1000 digi-
tal camera. 16 non-overlapping images were obtained and used for all
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bers) by an experimenter in a manual way; experimenter was blind to
the samples' provenience (Tau-null and Tau+/+; 5 animals per
genotype).Ex-vivo measurement of compound action potentials
Acutely isolated sciatic nerves from Tau-null and Tau+/+ animals
(5–6 animals per group) were used for assessment of A- and C-ﬁber
conduction velocity and compound action potential (CAP) area as previ-
ously described (Pinto et al., 2008). Brieﬂy, sciatic nerveswere dissected
and cleaned from the connective tissue sheath in artiﬁcial cerebrospinal
ﬂuid (ACSF) containing (in mM): 124 NaCl, 2.5 KCl, 1 MgSO4, 2 CaCl2,
1.25 NaH2PO4, 26 NaHCO3, and 10 Glucose, bubbled with carbogen gas
(95% O2, 5% CO2). After isolation, the nerves were used at room temper-
ature of 22–24 °C. CAP recordings were made with a Multiclamp 700B
ampliﬁer in VC mode and digitized with the Digidata 1440A digitizer
using pClamp 10 software (Axon Instruments). Signals were low-pass
ﬁltered at an effective corner frequency of 16 kHz and sampled at
50 kHz. Fibers were stimulated through suction electrodes using an iso-
latedpulse stimulator (STG4002,multichannel systems). Short pulses of
50 μs were applied to activate CAPs in Aαβ- and Aδ-ﬁbers. C-ﬁberswere
stimulated with 1 ms current pulses. Sciatic nerves were repeatedly
stimulated with current pulses of increasing amplitudes until satura-
tion. Conduction velocities were calculated for the CAP peak of A-
ﬁbers and for the ﬁrst peak of the C-ﬁber biphasic CAP. Total areas
were calculated using clampﬁt software (Axon Instruments). Electro-
physiological recordings and analyses were performed by an experi-
menter blind to the provenience of the tissue.Western blot analysis
Sciatic nerves of undisturbed Tau-null and Tau+/+ animals (6–7
animals per genotype) were isolated and homogenized in lysis buffer
[10 mM HEPES pH 7.9, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 10%
glycerol, 1% NP-40, Complete Protease Inhibitor (Roche, Mannheim,
Germany) and Phosphatase Inhibitor Cocktails II and III (Sigma, St
Louis, MO)] using a Dounce glass homogenizer; extracts were sonicated
and centrifuged (15.000 g; 10 min; 4 °C) and their protein contents
were estimated (Bradford assay). After reconstitution in Laemmli buffer
(250 mM Tris–HCl, pH 6.8, containing 4% sodium dodecyl sulfate, 10%
glycerol, 2% b-mercaptoethanol and 0.002% bromophenol blue), 25 μg
of lysates was electrophoresed on 10% acrylamide gels, and transferred
onto nitrocellulose membranes (BIORAD Turbo) while transfer efﬁcacy
was checked bymembrane Ponceau staining. Membraneswere blocked
in Tris-buffered saline containing 5% non-fat milk and 0.2% Tween-20
before incubation with myelin basic protein (MBP) antibody (Serotec;
1:500) and actin (DSHB 1:2000). Antigens were revealed by enhanced
chemiluminescence (BIORAD) after incubation with appropriate horse-
radish peroxidase–immunoglobulin G conjugates (BIORAD). Protein
ladder (Fermentas) was used to monitor molecular weight of proteins
of interest. Blots were scanned and quantiﬁed using TINA 3.0
bioimaging software (Raytest, Germany). All values were normalized
against actin and expressed as percentages of control.Statistical analysis
All data sets were subjected to t-test analysis except c-fos expres-
sion data that were analyzed by 2-way ANOVA having genotype
(Tau+/+ vs Tau−/−) and treatment (saline vs formalin) as
factors and it was followed by Tukey post-hoc analysis (SPSS,
Aspire Software, USA). Differences were considered to be signiﬁcant
if p b 0.05.Results
Tau-null animals present decreased nociception to acute noxious but the
opposite to tonic stimulation
For detailed characterization of Tau involvement in nociception,
Tau-null and Tau+/+ (wild-type) animals were submitted to different
pain-related behavioral tests that are used to examine relevant pain-
like responses. The response latency to acute noxious heat (54 °C) on
the hind paw (Hargreaves' test) was signiﬁcantly increased in Tau-
null when compared to wild type animals (t= 2.865, p b 0.05) indicat-
ing reduced nociception to acute noxious stimuli (Fig. 1A). Furthermore,
we evaluated inﬂammatory pain in both genotypes using the formalin
test. Pain-related behaviors such as protecting/licking and paw jerks
were monitored for 1 h after subcutaneous paw injection of formalin
in the right hind paw (Figs. 1B and C). In line with the above test of
acute pain, the acute phase of the formalin test (0–5 min) shows that
Tau-null animals spent less time engaged in pain-related behaviors as
indicated by the time of protecting/licking the formalin-injected paw
(t = 2.162, p b 0.05; Fig. 1B left). In addition, Tau-null animals
displayed decreased number of jerks of the formalin-injected paw
when compared to Tau+/+ (t= 2.933, p b 0.05; Fig. 1C left); both typ-
ical pain-related behaviors induced by formalin suggest that Tau-null
animals respond less to the acute phase of formalin noxious stimulation.
Interestingly, animals from the two genotypes exhibit a different re-
sponse proﬁle in the tonic phase of the formalin test (15–60 min). Spe-
ciﬁcally, an increased protecting/licking behavior was found in Tau-null
animals when compared to Tau+/+ animals (t = 2.089, p b 0.05;
Fig. 1B right) indicating increased pain, though no signiﬁcant difference
in the number of paw jerks (Fig. 1C right). Importantly, Tau-null and
Tau+/+ animals presented no differences in their response threshold
to innocuous lightmechanical stimulus (Fig. 1D) suggesting that normal
tactile sensation is preservedwhile the observed alterations phenotypes
were restricted to pain.
Spinal cord formalin-induced c-fos expression is higher in Tau-null animals
c-fos positive cell density is used as a central correlate of pain-related
neuronal activity driven by formalin stimulation of peripheral afferents
(Fig. 2A). Thus, wemeasured c-fos-positive neurons in lumbar L4–L6 spi-
nal cordof the formalin- and saline-injected animals. 2-WayANOVAanal-
ysis showed that c-fos cell density in ipsilateral and contralateral I–II
(superﬁcial) and III–IV (deep) spinal cord lamina was signiﬁcantly
dependent on the treatment (formalin vs saline: ipsiI–II F1,21 = 29.039;
contraI–II F1,21 = 42.714; ipsiIII–V F1,21 = 31.321; contraIII–V F1,21 =
22.159; p b 0.001 in all cases) and genotype (Tau-null vs Tau+/+:
ipsiI–II F1,21 = 4.560, p = 0.047; contraI–II F1,21 = 25.746, p b 0.001;
ipsiIII–V F1,21 = 5.372, p = 0.032; contraIII–V F1,21 = 9.016, p = 0.008).
Also, the interaction of these factors resulted signiﬁcantly in almost
all comparisons — ipsiI–II F1,21 = 4.098, p = 0.058; contraI–II F1,21 =
20.892, p b 0.001; ipsiIII–V F1,21 = 5.343, p = 0.033; contraIII–V F1,21 =
6.490, p= 0.020. As shown in Fig. 2B, formalin injection resulted in an ex-
pected increased c-fos + density in the ipsilateral dorsal horn.
However, this effect had a higher magnitude in Tau-null animals
matching with their increased pain-related behavioral responses
at the tonic phase of the formalin test. Interestingly, Tau-null
animals demonstrated an abnormal c-fos staining at both layers
I–II and III–V of the contralateral side of spinal cord as shown in
Fig. 2A.
Tau-null sciatic nerves exhibit reduced myelination and decreased density
of non-myelinated ﬁbers
As Tau-null animals exhibit alteration in pain sensitivity, it was of
great interest to monitor the structure and functionality of the sciatic
nerve ﬁbers that convey sensory input from the hind paw to the CNS.
Fig. 1. Tau-null animals exhibit altered nociception. Tau-null (Tau−/−) and Tau+/+ animals were tested with noxious heat (A), inﬂammatory (B–C), and light mechanical stimuli (D).
A) Tau−/− animals presented increased time in paw withdraw to acute noxious (heat; 54 °C) stimuli in Hargreaves' test indicating reduced pain behavior. B–C) At the acute phase of
formalin test, Tau−/− animals exhibit reduced time of protecting/licking the formalin-injected paw (B; left part) as well as reduced number of paw jerks (C; left part); both pain-
related behaviors reﬂect diminished nociception. In contrast, the licking/protecting time of Tau-null animals was higher than Tau+/+ during the tonic phase of formalin test (B, right
part). D) Tau-null and Tau+/+ animals presented no differences in the response to innocuous stimulus (light mechanical). Data presented as mean ± SEM; *p b 0.05.
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transmission electron microscopy (Fig. 3A). As shown in Fig. 3B, Tau-
null animals have reduced density of non-myelinated ﬁbers (C-ﬁbers)
(t= 2.515, p b 0.05), even though thenumber of non-myelinatedﬁbers
per Remak bundlewas not affected (Fig. 3C). On the contrary, therewas
no difference in density of myelinated ﬁbers between Tau-null and
Tau+/+ animals as assessed by p-phenylene diamine (PPD) staining
(Fig. 3D). Furthermore, we determined the g-ratio, an index of
myelination independent of axonal diameter (Michailov et al., 2004),
in sciatic nerves of animals of both genotypes (Fig. 4A). As shown in
Fig. 4B, themean g-ratio of Tau-null animals was signiﬁcantly increased
(t = 10.65, p b 0.05) indicating thinner myelin sheaths in their sciatic
nerve. Regarding the overall axonal population, the percentage of
small-diameter myelinated axons (with diameter less than 4 μm) was
signiﬁcantly increased in Tau-null animals compared to Tau+/+ ones
(72.75% ± 0.85 and 65.40% ± 2.50, respectively; t = 2.505, p b 0.05)
indicating that the biggest difference in the individual g-ratios was
found in the small-diameter ﬁbers (Fig. 4C). Moreover, we monitored
the levels of one of themain proteins found in compactmyelin, themy-
elin basic protein (MBP) in sciatic nerves of Tau-null and Tau+/+ ani-
mals using western blot analysis. As shown at Fig. 4D, we found
decreased levels of MBP protein in Tau-null animals, providing further
support to the hypomyelination phenotype found by g-ratio analysis.
Sciatic nerve myelinated/unmyelinated CAPs ratio is reduced in Tau-null
The above morphological and molecular ﬁndings prompted us to
monitor the functionality of sciatic nerve by measuring the conduction
velocity of A- andC-ﬁbers. For that purpose, Tau+/+andTau−/− sciatic
nerves were repeatedly stimulated with current pulses of increasing am-
plitudes until saturation (Figs. 5A, B). As shown in Fig. 5C, no differenceswere found in the conduction velocity of Tau-null and Tau+/+ animals
of both large-diameter myelinated (A-) and non-myelinated (C-) ﬁbers.
However, the ratio of the total area of the compound action potentials
(CAPs) of myelinated vs unmyelinated ﬁbers was signiﬁcantly increased
in Tau-null animals (t= 2.367, p b 0.05; Fig. 5D) indicating an overall al-
teration in conduction properties of sciatic nerve of Tau-null animals.
Discussion
This study provides the ﬁrst evidence that Tau depletion affects no-
ciceptive behavior in mice and leads to morphofunctional alterations in
primary afferent ﬁbers. Our ultrastructural and biochemical analysis
demonstrates a hypomyelination phenotype in sciatic nerves of Tau-
null animals. Indeed, a previous cell culture-based study by Klein et al.
suggests the involvement of Tau protein in CNS myelin formation
through its structural interaction with Fyn protein and microtubules
(Klein et al., 2002). Transgenic loss of Fyn or its function is shown to re-
sult in severe hypomyelination (Sperber andMcMorris, 2001; Umemori
et al., 1994) but upstream partner of Fyn can also promote myelination
independently of Fyn (Bifﬁger et al., 2000); the latter may explain why
loss of Tau does not completely abrogate the myelination process in
Tau-null mice. Supporting the involvement of Tau and microtubules in
myelination process, the Taiep myelin mutant rats exhibit irregular mi-
crotubules, abnormal Tau accumulation and intracellular accumulation
of myelin proteins in oligodendrocytes (Song et al., 2001), while PNS
myelin-deﬁcient mice exhibited reduction of Tau as well as other
microtubule-associated proteins in their sciatic nerves (Kirkpatrick
and Brady, 1994). A possible mechanism suggested by Song et al. focus-
es on the importance of Tau and microtubules in the transport of vesi-
cles (Dixit et al., 2008) containing myelin components to the sheath
formation of myelinating cells. On the other hand, as neuron-glial cell
Fig. 2. Tau-null animals demonstrate higher c-fos staining in spinal cord at the end of formalin noxious stimulation. Representative immunohistochemical images (A) and quantitative
analysis (B) of c-fos staining at spinal cord of Tau-null (Tau−/−) and Tau+/+ mice at the end of formalin test. Formalin injection at the right paw of the animals resulted in strong c-
fos staining in the ipsilateral dorsal horn layer I/II where the majority of nociceptive signal from paw neurons arrives (superior right quadrant). Note that this formalin effect is higher
in Tau-null animals than Tau+/+ ones (A, B). Right images are high-power magniﬁcations of the rectangular areas marked in the respective low-magniﬁcation micrographs (ipsilateral
dorsal horn). In addition, Tau-null animals exhibit an abnormal (contralateral) c-fos staining induced by formalin; representative images of saline-injected animals on the left. All numer-
ical data shown represent mean ± SEM. For individual comparisons, data were analyzed by one-way ANOVA followed by Tukey HSD post-hoc. *p b 0.05, **p b 0.01 and ***p b 0.001.
490 I. Sotiropoulos et al. / Experimental Neurology 261 (2014) 486–493interaction(s) are essential for myelination, some studies showed that
axonopathies are accompanied by myelin deﬁcits (Wirths et al., 2006)
raising the question whether axonal disturbances in neurons are pre-
ceded by the myelin deﬁcits in myelinating (oligodendrocytes or
Schwann) cells.
According to our observations, myelin alterations are restricted to
small caliber axons (b4 μm). Indeed, Tau protein is highly expressed
in small-caliber axons of both adult CNS and PNS (low and high molec-
ular weight Tau isoforms, respectively). Large-diameter axons on the
other hand express very little amount of Tau (Nothias et al., 1995;
Sato-Yoshitake et al., 1989). Accordingly, Harada and colleagues found
that microtubule alterations were restricted to small-size axons in
Tau-KO animals (Harada et al., 1994). This may result from the fact
that, in contrast to large-caliber axons, Tau is the predominant MT-
associated protein in small and medium caliber axons and thus, upon
its depletion, Tau function in small-caliber axons cannot easily be com-
pensated by other MT-associated proteins such as MAP1A, which is
temporally increased in Tau-KO animals (Dawson et al., 2001; Harada
et al., 1994).Furthermore, we demonstrate a reduction in unmyelinated C-ﬁber
density in sciatic nerve of Tau-null animals; importantly, unmyelinated
C-ﬁbers and smallmyelinated (Aδ)ﬁbers are themajor systems convey-
ing nociceptive inputs to the spinal cord although the participation of
large myelinated Aα/β ﬁbers has also been demonstrated (Djouhri
and Lawson, 2004; Todd, 2010). Tau depletion and the resulting loss
of MT–Tau interaction may have a higher impact on C-ﬁbers than on
A-ﬁbers as the MT/neuroﬁlaments ratio in sciatic nerve is higher in un-
myelinated ﬁbers and thus, C-ﬁbers may be structurally more depen-
dent on these cytoskeleton elements (Friede and Samorajski, 1970).
As a result, the overall ratio between unmyelinated/myelinated ﬁbers
was affected in Tau-null animals indicating a reorganization of the over-
all composition of the nerveﬁbers; thiswas in linewith the electrophys-
iological monitoring of sciatic nerve functionality that shows an overall
decrease in the proportion of total area of the compound action poten-
tials (CAPs) of myelinated vs unmyelinated ﬁbers. However, it is impor-
tant to note that there were no major conduction velocity changes in
both large myelinated and the remaining unmyelinated ﬁbers suggest-
ing that the existing ﬁbers are properly conducting.
Fig. 3. Morphometric analyses of sciatic nerve ultrastructure. A) Representative images of Tau−/− and Tau+/+ sciatic nerve ultrastructure where Remak bundles are marked
(white asterisk). B–C) Tau−/− animals exhibit a signiﬁcant reduction of non-myelinated ﬁber (C-ﬁbers) density when compared to Tau+/+ animals although no alterations in number
ofﬁbers per Remak bundlewere found between the two genotypes. D) Conversely, the number ofmyelinatedﬁberswas unaltered in sciatic nerves of Tau−/− animals. Data presented as
mean ± SEM; *p b 0.05.
491I. Sotiropoulos et al. / Experimental Neurology 261 (2014) 486–493Tau-null animals demonstrated a decrease in pain sensitivity in the
acute phase of the formalin test (ﬁrst 5 min of noxious stimuli) that is
in agreement with the results of the Hargreaves' test where a decreaseFig. 4. Tau-null sciatic nerve presents hypomyelination phenotype. A) Representative images o
ratio analysis. B–C) Tau−/− animals demonstrated increased g-ratio [axon diameter / (
hypomyelination, particularly evident in small myelinated ﬁbers. D) Representative blots and
nerves assessed by WB analysis. Note the reduced MBP levels in sciatic nerves of Tau−/− animin acute pain sensitivity in response to noxious (thermal) stimuli was
also found. Although our pain-related behavioral readouts are motor-
dependent, we can exclude potential confounders as no motor orf PPD (p-phenylenediamine) staining of Tau−/− and Tau+/+ sciatic nerves used for g-
axon diameter + myelin thickness)] in comparison to Tau+/+ animals indicating
semi-quantitative measurement of protein levels of myelin basic protein (MBP) in sciatic
als. Data presented as mean ± SEM; *p b 0.05.
Fig. 5. Sciatic nerve conduction properties are affected in Tau absence. A, B) Representative traces of sciatic nerve CAPs are presented for A- and C-ﬁbers of Tau+/+ (A) and Tau−/− (B).
Tau+/+ and Tau−/− sciatic nerveswere repeatedly stimulatedwith current pulses of increasing amplitudes until saturation (conduction distance: 9.3mmand 9.6mm for Tau+/+ and
Tau−/−, respectively); traces are averages of 5 consecutive recordings. C–D)While no differences of absolute conduction velocity between Tau−/− and Tau+/+ animals were found
(C), the ratio of the A-ﬁber/C-ﬁber activity (as measured by total area of the CAP responses) was increased in Tau−/− animals pointing towards altered overall conduction properties in
Tau−/− sciatic nerve (D). Data presented as mean ± SEM; *p b 0.05.
492 I. Sotiropoulos et al. / Experimental Neurology 261 (2014) 486–493muscle strength deﬁcits have been found in adult Tau-KO animals used
in this study (Dawson et al., 2010; Gotz et al., 2013) while Tau-KO nor-
mal response to innocuous mechanical stimuli with reﬂex withdrawal
(Von Frey) indicates that the acute pain (thermal) deﬁcits assessed by
Hargreaves' test were not due to a disruption of ﬂexor motor neuron
function. Thus, as acute pain is primarily dependent on primary afferent
transmission, with limited intervention of central sensitization mecha-
nisms (Liu et al., 2008), this decrease in acute pain is probably
dependent on the reduction in unmyelinated C-ﬁbers and the
hypomyelination of Aδ-ﬁbers. Previous studies reported a reduced re-
sponse to neuropathy-triggered mechanical allodynia in animals lack-
ing Fyn which exhibit a clear hypomyelination phenotype (Abe et al.,
2005). The close interaction between Fyn and Tau (Klein et al., 2002)
could explain the similarities between our and previous observations.
Contrary to the acute phase, the tonic phase of the formalin test is
centrally mediated. In agreement, c-fos expression in the dorsal horn
was augmented reﬂecting the increased pain-related behavior observed
in Tau-null animals. The increased excitability of second order spinal
cord nociceptive neurons, could be explained by a mechanism where
a decrease in afferent inputs, due to a restrain in synaptic transmission(D'Mello et al., 2011; Ittner and Gotz, 2011; Roberson et al., 2007),
and in nociceptive conducting ﬁbers, is compensated by an increase in
somatic neuronal excitability to maintain a balanced spinal nociceptive
circuit in Tau-null mice (Turrigiano, 2011). Alternatively, a decrease in
spinal inhibition, caused by a decreased activity of the inhibitory circuit,
could also account for such results (Zeilhofer et al., 2012). Overall, the
centrally mediated hyperexcitability we described most probably also
accounts for the contralateral c-fos expression observed in Tau-null
mice. It is noteworthy that morphine-tolerant hyperalgesic animals ex-
hibit a similar abnormal c-fos pattern in spinal cord (Rohde et al., 1997).
Further analysis of the role of Tau on mechanisms of synaptic plasticity
and neurotransmission at spinal cord is needed to clarify the above
issue.
Conclusions
The present study provides the ﬁrst in vivo evidence supporting the
involvement of Tau protein in pain perception. This study suggests that,
in the absence of Tau, two phenomena take place: i) nerve structural
and functional alterations (e.g. reduced C-ﬁber density and Aδ-ﬁber
493I. Sotiropoulos et al. / Experimental Neurology 261 (2014) 486–493hypomyelination) leading todecreased sensation to acute noxious stim-
uli and ii) increased excitability of second order spinal cord nociceptive
neurons resulting in heightened pain-like behaviors in the tonic phase
of formalin test. In the light of recent evidence suggesting novel roles
for Tau at synaptic structure and function, future studies are necessary
to clarify the mechanistic role of Tau in pain sensitization as this study
suggests Tau-dependent alterations in the spinal nociceptive circuitry.
Altogether, these ﬁndings are likely to be of relevance to understand
the mechanisms underlying the clinical observations of myelin loss
and diminished pain perception in AD patients (Bartzokis, 2011;
Corbett et al., 2012).
Conﬂict of interest statement
Authors declare no conﬂicts of interest associated to this work.
Acknowledgments
Wewould like to thankDrs João Relvas, Joana Paes de FariaMonteiro
and Nuno Dias for their comments in this work. Many thanks to Dr João
Relvas for theMBP antibody. The work was supported by grants “SFRH/
BPD/80118/2011”, “PTDC/SAU-NMC/113934/2009” funded by FCT —
Portuguese Foundation for Science and Technology and project DoIT —
Desenvolvimento e Operacionalização da Investigação de Translação (No.
do projeto 13853), funded by Fundo Europeu de Desenvolvimento
Regional (FEDER) through the Programa Operacional Fatores de
Competitividade (POFC). Author's contributions: experimental design —
IS, HA, VP, AA, and NS; performed research — IS, HA, VP, AL, SL, SS, SP,
AC, FPR, and RF; data analyses— IS, HA, AL, VP, SC, and FPR; and manu-
script preparation — IS, HA, VP, and NS.
References
Abe, T.,Matsumura, S.,Katano, T.,Mabuchi, T.,Takagi, K.,Xu, L.,Yamamoto, A.,Hattori, K.,
Yagi, T.,Watanabe, M.,Nakazawa, T.,Yamamoto, T.,Mishina, M.,Nakai, Y.,Ito, S., 2005.
Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472
is essential for maintenance of neuropathic pain. Eur. J. Neurosci. 22, 1445–1454.
Almeida, A.,Storkson, R.,Lima, D.,Hole, K.,Tjolsen, A., 1999. The medullary dorsal reticular
nucleus facilitates pain behaviour induced by formalin in the rat. Eur. J. Neurosci. 11,
110–122.
Bartzokis, G., 2011. Alzheimer's disease as homeostatic responses to age-related myelin
breakdown. Neurobiol. Aging 32, 1341–1371.
Bifﬁger, K., Bartsch, S.,Montag, D., Aguzzi, A., Schachner, M., Bartsch, U., 2000. Severe
hypomyelination of the murine CNS in the absence of myelin-associated glycoprotein
and fyn tyrosine kinase. J. Neurosci. 20, 7430–7437.
Chaplan, S.R., Bach, F.W.,Pogrel, J.W., Chung, J.M., Yaksh, T.L., 1994. Quantitative assess-
ment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55–63.
Chen, S.,Rio, C., Ji, R.R.,Dikkes, P.,Coggeshall, R.E.,Woolf, C.J.,Corfas, G., 2003. Disruption of
ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive
sensory loss. Nat. Neurosci. 6, 1186–1193.
Corbett, A., Husebo, B., Malcangio, M., Staniland, A., Cohen-Mansﬁeld, J., Aarsland, D.,
Ballard, C., 2012. Assessment and treatment of pain in people with dementia. Nat.
Rev. Neurol. 8, 264–274.
Dawson, H.N.,Ferreira, A.,Eyster, M.V.,Ghoshal, N.,Binder, L.I.,Vitek, M.P., 2001. Inhi-
bition of neuronal maturation in primary hippocampal neurons from tau deﬁ-
cient mice. J. Cell Sci. 114, 1179–1187.
Dawson, H.N., Cantillana, V., Jansen, M.,Wang, H., Vitek, M.P.,Wilcock, D.M., Lynch, J.R.,
Laskowitz, D.T., 2010. Loss of tau elicits axonal degeneration in a mouse model of
Alzheimer's disease. Neuroscience 169, 516–531.
Dixit, R.,Ross, J.L.,Goldman, Y.E.,Holzbaur, E.L., 2008. Differential regulation of dynein and
kinesin motor proteins by tau. Science 319, 1086–1089.
Dixon, W.J., 1980. Efﬁcient analysis of experimental observations. Annu. Rev. Pharmacol.
Toxicol. 20, 441–462.Djouhri, L.,Lawson, S.N., 2004. Abeta-ﬁber nociceptive primary afferent neurons: a review
of incidence and properties in relation to other afferent A-ﬁber neurons in mammals.
Brain Res. Brain Res. Rev. 46, 131–145.
D'Mello, R.,Marchand, F.,Pezet, S.,McMahon, S.B.,Dickenson, A.H., 2011. Perturbing PSD-
95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity
and neuropathic pain. Mol. Ther. 19, 1780–1792.
Frandemiche, M.L.,De Seranno, S., Rush, T., Borel, E., Elie, A.,Arnal, I., Lante, F., Buisson, A.,
2014. Activity-dependent tau protein translocation to excitatory synapse is disrupted
by exposure to amyloid-beta oligomers. J. Neurosci. 34, 6084–6097.
Friede, R.L.,Samorajski, T., 1970. Axon caliber related to neuroﬁlaments and microtubules
in sciatic nerve ﬁbers of rats and mice. Anat. Rec. 167, 379–387.
Gotz, J.,Xia, D.,Leinenga, G.,Chew, Y.L.,Nicholas, H., 2013. What renders TAU toxic. Front.
Neurol. 4, 72.
Harada, A.,Oguchi, K.,Okabe, S.,Kuno, J.,Terada, S.,Ohshima, T.,Sato-Yoshitake, R.,Takei, Y.,
Noda, T.,Hirokawa, N., 1994. Altered microtubule organization in small-calibre axons
of mice lacking tau protein. Nature 369, 488–491.
Ittner, L.M.,Gotz, J., 2011. Amyloid-beta and tau—a toxic pas de deux in Alzheimer's dis-
ease. Nat. Rev. Neurosci. 12, 65–72.
Jaggi, A.S., Singh, N., 2012. Mechanisms in cancer-chemotherapeutic drugs-induced pe-
ripheral neuropathy. Toxicology 291, 1–9.
Kirkpatrick, L.L.,Brady, S.T., 1994. Modulation of the axonal microtubule cytoskeleton by
myelinating Schwann cells. J. Neurosci. 14, 7440–7450.
Klein, C.,Kramer, E.M.,Cardine, A.M.,Schraven, B.,Brandt, R.,Trotter, J., 2002. Process out-
growth of oligodendrocytes is promoted by interaction of fyn kinase with the cyto-
skeletal protein tau. J. Neurosci. 22, 698–707.
Liu, X.J.,Gingrich, J.R.,Vargas-Caballero, M.,Dong, Y.N.,Sengar, A.,Beggs, S.,Wang, S.H.,Ding,
H.K.,Frankland, P.W.,Salter, M.W., 2008. Treatment of inﬂammatory and neuropathic
pain by uncoupling Src from the NMDA receptor complex. Nat. Med. 14, 1325–1332.
Liu, Y.N., Yang, X., Suo, Z.W., Xu, Y.M., Hu, X.D., 2014. Fyn kinase-regulated NMDA
receptor- and AMPA receptor-dependent pain sensitization in spinal dorsal
horn of mice. Eur. J. Pain. http://dx.doi.org/10.1002/j.1532-2149.2014.00455.x
(Electronic publication ahead of print).
Mandelkow, E.M.,Mandelkow, E., 2012. Biochemistry and cell biology of tau protein in
neuroﬁbrillary degeneration. Cold Spring Harb. Perspect. Med. 2, a006247.
Michailov, G.V.,Sereda, M.W.,Brinkmann, B.G.,Fischer, T.M.,Haug, B.,Birchmeier, C.,Role, L.,
Lai, C., Schwab, M.H.,Nave, K.A., 2004. Axonal neuregulin-1 regulates myelin sheath
thickness. Science 304, 700–703.
Nothias, F.,Boyne, L.,Murray, M.,Tessler, A.,Fischer, I., 1995. The expression and distribu-
tion of tau proteins and messenger RNA in rat dorsal root ganglion neurons during
development and regeneration. Neuroscience 66, 707–719.
Ottoni, E.B., 2000. EthoLog 2.2: a tool for the transcription and timing of behavior obser-
vation sessions. Behav. Res. Methods Instrum. Comput. 32, 446–449.
Pinto, V.,Derkach, V.A., Safronov, B.V., 2008. Role of TTX-sensitive and TTX-resistant
sodium channels in Adelta- and C-ﬁber conduction and synaptic transmission.
J. Neurophysiol. 99, 617–628.
Pinto-Ribeiro, F., Amorim, D., David-Pereira, A.,Monteiro, A.M., Costa, P., Pertovaara, A.,
Almeida, A., 2013. Pronociception from the dorsomedial nucleus of the hypothalamus
is mediated by the rostral ventromedial medulla in healthy controls but is absent in
arthritic animals. Brain. Res. Bull. 99C, 100–108.
Reichling, D.B.,Levine, J.D., 2011. Pain and death: neurodegenerative disease mechanisms
in the nociceptor. Ann. Neurol. 69, 13–21.
Roberson, E.D., Scearce-Levie, K.,Palop, J.J.,Yan, F.,Cheng, I.H.,Wu, T.,Gerstein, H.,Yu, G.Q.,
Mucke, L., 2007. Reducing endogenous tau ameliorates amyloid beta-induced deﬁcits
in an Alzheimer's disease mouse model. Science 316, 750–754.
Rohde, D.S.,Detweiler, D.J.,Basbaum, A.I., 1997. Formalin-evoked Fos expression in spinal
cord is enhanced in morphine-tolerant rats. Brain Res. 766, 93–100.
Sato-Yoshitake, R.,Shiomura, Y.,Miyasaka, H.,Hirokawa, N., 1989. Microtubule-associated
protein 1B: molecular structure, localization, and phosphorylation-dependent ex-
pression in developing neurons. Neuron 3, 229–238.
Song, J.,Goetz, B.D.,Kirvell, S.L.,Butt, A.M.,Duncan, I.D., 2001. Selective myelin defects in
the anterior medullary velum of the taiep mutant rat. Glia 33, 1–11.
Sperber, B.R.,McMorris, F.A., 2001. Fyn tyrosine kinase regulates oligodendroglial cell de-
velopment but is not required for morphological differentiation of oligodendrocytes.
J. Neurosci. Res. 63, 303–312.
Todd, A.J., 2010. Neuronal circuitry for pain processing in the dorsal horn. Nat. Rev.
Neurosci. 11, 823–836.
Turrigiano, G., 2011. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in
cortical circuit reﬁnement. Annu. Rev. Neurosci. 34, 89–103.
Umemori, H.,Sato, S.,Yagi, T.,Aizawa, S.,Yamamoto, T., 1994. Initial events of myelination
involve Fyn tyrosine kinase signalling. Nature 367, 572–576.
Wirths, O.,Weis, J.,Szczygielski, J.,Multhaup, G.,Bayer, T.A., 2006. Axonopathy in anAPP/PS1
transgenic mouse model of Alzheimer's disease. Acta Neuropathol. 111, 312–319.
Zeilhofer, H.U.,Wildner, H.,Yevenes, G.E., 2012. Fast synaptic inhibition in spinal sensory
processing and pain control. Physiol. Rev. 92, 193–235.
